TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index

NCT07517276 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development

Interventions

DRUG: tauroursodeoxycholic acid (TUDCA)
DRUG: Placebo

Sponsor

Peking University First Hospital